BREAKTHROUGH Pfizer and German partner BioNTech SE estimate they can roll out up to 50 million doses of their COVID-19 vaccine this year, enough to protect 25 million people, and then produce up to 1.3 billion doses in 2021. —REUTERS
“When it comes to the data submitted to these kinds of regulatory bodies, we are talking confidential information about the vaccine and its mechanism of action, its efficiency, its risks & known possible side effects and any unique aspects such as handling guidelines,” said Marc Rogers, founder of a volunteer group fighting Covid-related breaches, CTI-League.
A spokeswoman for BioNTech declined further comment. Pfizer did not respond to a request for further comment. Hacking attempts against healthcare and medical organisations have intensified during the COVID-19 pandemic as attackers ranging from state-backed spies to cyber criminals hunt for information.